Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Completes SNP Assay Project with Nat'l Cancer Institute

Premium

Genotyping tools developer Sequenom, of San Diego, said it had completed a SNP assay design and validation project done in conjunction with the US National Cancer Institute.

Sequenom’s automated assay design process and MassARRAY system were used to develop more than 9,000 assays to confirm and validate SNPs in a reference population.

Following the completion of the first leg of the project, Sequenom will now aim to develop an additional set of 10,000 SNP assays for confirmation and validation.

As a result of the project, Sequenom can run high-throughput analyses on the SNPs as well as provide data and genetic information along with the company’s MassARRAY subscriptions.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.